Related Experiment Video
Updated: Apr 17, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
Published on: January 27, 2023
Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors
Stina Betts1, Linda Björkhem-Bergman2, Anders Rane1
1Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Abstract:
Previous reports have suggested that the nuclear receptors vitamin D receptor (VDR), peroxisome proliferator-activated receptor α (PPARα), pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are involved in the regulation of the drug-metabolizing enzyme cytochrome P450 (CYP) 3A4 expression in adults. The aim of this study was to investigate the gene expression of CYP3A4 and the foetal CYP3A7 in human foetal tissues and their relation to gene expression and genetic variations in the nuclear receptors VDR, PPARα, PXR and CAR. We determined the relative expression of CYP3A4 and CYP3A7 and these nuclear receptors in foetal livers, intestines and adrenals, using quantitative PCR. In addition, the expression of these enzymes was also analysed in adult liver. There was a high interindividual variability in CYP3A4 and CYP3A7, 49 times and 326 times, respectively. Both CYP3A4 and CYP3A7 had the highest expression in the liver. There were significant correlations (p < 0.001) between the nuclear receptors studied and the expression of CYP3A4 and CYP3A7 in foetal liver, as well as the expression of CYP3A4 in foetal intestine. Polymorphisms in the VDR gene, rs1544410 and rs1523130 (TaqI), in the PXR gene, rs1523130, and in the PPARα gene, rs4253728, were not correlated with CYP3A4 or CYP3A7 expression. However, C-homozygous individuals of the TaqI VDR polymorphism had 60% lower VDR gene expression (p < 0.05), than individuals carrying one or two T alleles. In conclusion, differences in the expression of nuclear receptors might determine the variability in CYP3A4 and CYP3A7 expression observed in foetal liver.
Insights
Nuclear receptors like VDR, PPARα, PXR, and CAR influence fetal CYP3A4 and CYP3A7 gene expression, particularly in the liver. Genetic variations in these receptors did not correlate with CYP3A4/CYP3A7 levels, but VDR polymorphisms affected VDR expression.
Area of Science:
- Pharmacology
- Developmental Biology
- Genetics
Background:
- Nuclear receptors, including vitamin D receptor (VDR), peroxisome proliferator-activated receptor α (PPARα), pregnane X receptor (PXR), and constitutive androstane receptor (CAR), are known to regulate drug-metabolizing enzyme cytochrome P450 (CYP) 3A4 expression in adults.
- Understanding these regulatory mechanisms in fetal development is crucial for predicting drug metabolism and potential toxicities during early life stages.
Purpose of the Study:
- To investigate the gene expression of fetal CYP3A4 and CYP3A7 in human fetal tissues.
- To examine the relationship between the expression of nuclear receptors (VDR, PPARα, PXR, CAR) and the gene expression of CYP3A4 and CYP3A7 in fetal tissues.
- To explore the impact of genetic variations in these nuclear receptors on CYP3A4 and CYP3A7 expression.
Main Methods:
- Quantitative PCR was used to determine the relative expression of CYP3A4, CYP3A7, and the nuclear receptors VDR, PPARα, PXR, and CAR in fetal livers, intestines, and adrenals.
- Adult liver samples were also analyzed for enzyme expression.
- Genetic polymorphisms in VDR, PXR, and PPARα genes were assessed for their correlation with CYP3A4 and CYP3A7 expression.
Main Results:
- Significant interindividual variability was observed in both CYP3A4 (49-fold) and CYP3A7 (326-fold) expression, with highest levels in the liver.
- Significant correlations were found between the expression of studied nuclear receptors and CYP3A4/CYP3A7 expression in fetal liver, and CYP3A4 in fetal intestine (p < 0.001).
- No correlation was found between specific VDR, PXR, or PPARα gene polymorphisms and CYP3A4/CYP3A7 expression, although VDR polymorphisms affected VDR gene expression.
Conclusions:
- Differences in nuclear receptor expression levels are likely key drivers of the observed variability in fetal CYP3A4 and CYP3A7 expression.
- While specific genetic variations tested did not directly correlate with CYP3A4/CYP3A7 expression, the impact of polymorphisms on receptor expression warrants further investigation.
- These findings highlight the complex regulation of fetal drug metabolism enzymes and their potential variability.
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cell Specific Gene Expression

